ICU Medical, Inc. (ICUI)

Market Cap	2.33B
Revenue (ttm)	2.26B
Net Income (ttm)	-29.66M
Shares Out	24.14M
EPS (ttm)	-1.23
PE Ratio	n/a
Forward PE	20.02
Dividend	n/a
Ex-Dividend Date	n/a

Volume	127,404
Open	95.75
Previous Close	95.77
Day's Range	94.30 - 96.73
52-Week Range	78.28 - 212.43
Beta	0.71
Analysts	Strong Buy
Price Target	123.00 (+27.62%)
Earnings Date	May 6, 2024

About ICUI

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and elimina...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Mar 31, 1992
• Employees: 14,000
• Stock Exchange: NASDAQ
• Ticker Symbol: ICUI

Financial Performance

In 2023, ICU Medical's revenue was $2.26 billion, a decrease of -0.92% compared to the previous year's $2.28 billion. Losses were -$29.66 million, -60.08% less than in 2022.

Analyst Forecast

According to 3 analysts, the average rating for ICUI stock is "Strong Buy." The 12-month stock price forecast is $123.0, which is an increase of 27.62% from the latest price.

Price Target

$123.0

(27.62% upside)

Analyst Consensus: Strong Buy